druguse.pdf

U.S. Department of Health and Human Services
Report on the Effects of Regulation on Quality of Care: Analysis of the Effect of Regulation on the Quality of Care in Board and Care Homes
Charles Phillips, Linda Lux, Judith Wildfire, Angela Greene, Catherine Hawes, George Dunteman, Vince Iannacchione, Vincent Mor, Rebecca Green and

Drug data entry and related analyses were funded by a grant from the Geriatric Drug Therapy Research Institute to Brown University. Diana Spore was supported by the Agency for Health Care Policy and Research Training Grant T32-HS00011 awarded to Brown University.

scltrves.pdf

In the course of clinical investigations conducted under investigational new drug (IND) applications, information regarding adverse events must be communicated among investigators, sponsors, IRBs, and FDA in safety reports. There are a number of terms that are used to categorize adverse events and thereby determine which must be reported. The most

Treatment often involves empiric broad-spectrum antibacterial drug therapy, initially. Modifications of the antibacterial drug regimen can be made after urine culture and sensitivity analysis results are obtained. Mild to moderately ill patients may be treated in an outpatient setting with oral antibacterial drugs, such as norfloxacin or ciproflox

There is a need for specific and inexpensive rapid point of care (POC) diagnostic tests that can be used for clinical management of infectious diseases. Diagnostics are important as they allow tailoring treatment with antibacterial drugs, reducing unnecessary antibacterial drug use and thereby delaying the development of antibacterial resistance

The study examined the impact of the Medicare Replacement Drug Demonstration on patient access to care and patient outcomes, and analyzed its impact on Medicare spending, detailing cost savings to Medicare due to reduced physicians´ services and hospital outpatient department services for administration of replaced drugs. Over 42,000 Medicare ben

IMPROVE THE SAFETY, QUALITY, AFFORDABILITY AND ACCESSIBILITY OF HEALTH CARE INCLUDING BEHAVIORAL HEALTH CARE AND LONG TERM CARE
This Strategic Goal targets the need for people to be able to obtain and maintain affordable health care coverage, receive efficient high-quality health care services, and access appropriate information for informed

Contents
Limited-Service Hospital Pioneers: Challenges and Successes of the Essential Access Community Hospital/Rural Primary Care Hospital (EACH-RPCH) Program and Medical Assistance Facility (MAF) Demonstration
Comparative Study of the Use of EPSDT and Other Preventive and Curative Health Care Services by Children Enroll

Contents
Publications of the Patient Outcomes Research Teams (PORTS), May 1996 and Medical Treatment Effectiveness Projects 1989 through 1995
Final Report on Changes Needed in CONQUEST's Software Based Programs
Final Report on Changes Needed in CONQUEST 1.0's Structure and Classification Scheme
Assessment of the

Performance Improvement 1998 is the third annual report of the U.S. Department of Health and Human Services (HHS) on its evaluation activities. As a report to Congress, it summarizes the findings of HHS evaluations completed in fiscal year (FY) 1997. In that year, HHS agencies produced 155 evaluation reports and supported more than 335

Performance Improvement 1998 is the third annual report of the U.S. Department of Health and Human Services (HHS) on its evaluation activities. As a report to Congress, it summarizes the findings of HHS evaluations completed in fiscal year (FY) 1997. In that year, HHS agencies produced 155 evaluation reports and supported more than 335 evaluation

This report addressed how prescription coverage influenced the use of medical care when drug therapy substituted for or complemented other medical services. The research had three specific aims: (1) To examine the impact of drug coverage on drug expenditures and other expenditures covered by the Medicare program from 1995 to the latest available d

Pages

Survey Disclaimer

According to the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number. The valid OMB control number for this information collection is 0990-0379. The time required to complete this information collection is estimated to average 5 minutes per response, including the time to review instructions, search existing data resources, gather the data needed, and complete and review the information collection. If you have comments concerning the accuracy of the time estimate(s) or suggestions for improving this form, please write to: U.S. Department of Health & Human Services, OS/OCIO/PRA, 200 Independence Ave., S.W., Suite 336-E, Washington D.C. 20201, Attention: PRA Reports Clearance Officer.